OpenVSafe by OpenVAERS
Search V-safe

AAG-13753-48736

1 vaccination 1 coded response 4 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
301 / GA
Registered
2021-03-19
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Registered in v-safe
  2. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-19
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Rash, not including the immediate area around the injection site
    Adult check-in
  6. 2021-04-11
    Survey response — day 21, dose 1
    MedDRA: Feeling abnormal, Secretion discharge — Feeling: Poor · Be unable to work
    Free text: An overwhelming amount of mucus and brain fog
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-11
    Report sent to call center — day 21, dose 1
    Be unable to work
    no matching call case

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech

Call center

1 check-in flagged for a call with no call center case on record

See the call center timeline

Free text

Release 7 — day 21, dose 1

2021-04-11

Symptoms: An overwhelming amount of mucus and brain fog

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFeeling abnormal ✓ ✓ ✓
SDSecretion discharge ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release